RAD51 and neuroblastoma: In addition, elevated RAD51 protein expression has been found to be associated with poor survival in a variety of tumors, including ovarian cancers [37], lung cancers [38, 39], pancreatic cancers [40], esophageal cancers [32], neuroblastoma [41], and breast cancers [42].